[
  {
    "pk": 1, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C14", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Cardiovascular diseases", 
      "trial": 3, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C14.240.850.750.147", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Arteriovenous Fistula", 
      "trial": 1, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C14", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Cardiovascular diseases", 
      "trial": 4, 
      "version": "2010", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "23414", 
      "vocabulary": "ICD-10", 
      "level": "general", 
      "text": "", 
      "trial": 20, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C43-C44", 
      "vocabulary": "ICD-10", 
      "level": "general", 
      "text": "", 
      "trial": 22, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C18", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Nutritional and metabolic diseases", 
      "trial": 24, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "adfdfasd", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "", 
      "trial": 23, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C14", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Cardiovascular diseases", 
      "trial": 26, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 32, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C03", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Parasitic diseases", 
      "trial": 25, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 33, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C17", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Skin and connective tissue diseases", 
      "trial": 28, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 36, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "454545", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "XE321", 
      "trial": 30, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 37, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "C01", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Bacterial infections and mycoses", 
      "trial": 31, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 41, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 0, 
      "code": "E02.095.135.164", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Blood Transfusion, Autologous", 
      "trial": 14, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "50-81-7", 
      "vocabulary": "CAS", 
      "level": "specific", 
      "text": "L-Ascorbic acid", 
      "trial": 3, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "50-78-2", 
      "vocabulary": "CAS", 
      "level": "specific", 
      "text": "Benzoic acid, 2-(acetyloxy)-", 
      "trial": 1, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "C14.280.647", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Myocardial Ischemia", 
      "trial": 4, 
      "version": "2010", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "C22", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Animal diseases", 
      "trial": 20, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "C43-C44", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "", 
      "trial": 22, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "e11", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "Non-insulin dependent Diabetes mellitus ", 
      "trial": 24, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "c40", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "", 
      "trial": 23, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "B57.2", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "Trypanosomiasis with cardiac involvement", 
      "trial": 26, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 34, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "L80", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "vitiligo", 
      "trial": 28, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 38, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 1, 
      "code": "C20", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Immune system diseases", 
      "trial": 31, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "C14.280.647", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Myocardial Ischemia", 
      "trial": 3, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "C14.280.647.250.285", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Coronary Stenosis", 
      "trial": 4, 
      "version": "2010", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "3332", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "", 
      "trial": 20, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "C04", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Neoplasms", 
      "trial": 22, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "D09.546.359.448.500", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "glycemy", 
      "trial": 24, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "2222", 
      "vocabulary": "CAS", 
      "level": "general", 
      "text": "bevacizumab", 
      "trial": 23, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "C03", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Parasitic diseases", 
      "trial": 26, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 35, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "E01.370.600.620.750", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "skin pigmentation", 
      "trial": 28, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 39, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 2, 
      "code": "A15.9", 
      "vocabulary": "ICD-10", 
      "level": "specific", 
      "text": "Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically", 
      "trial": 31, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 3, 
      "code": "C14.280.647.250.260", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Coronary Artery Disease", 
      "trial": 3, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 3, 
      "code": "C14.280.647.250.285.200", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Coronary Restenosis", 
      "trial": 4, 
      "version": "2010", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 3, 
      "code": "C04", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "", 
      "trial": 22, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 3, 
      "code": "0000", 
      "vocabulary": "CAS", 
      "level": "general", 
      "text": "placebo", 
      "trial": 23, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 40, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 3, 
      "code": "D04.345.295.750.700", 
      "vocabulary": "DeCS", 
      "level": "general", 
      "text": "Rifampin", 
      "trial": 31, 
      "version": "", 
      "aspect": "Intervention"
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.descriptor", 
    "fields": {
      "_order": 4, 
      "code": "C14.280.647.250.285", 
      "vocabulary": "DeCS", 
      "level": "specific", 
      "text": "Coronary Stenosis", 
      "trial": 3, 
      "version": "", 
      "aspect": "HealthCondition"
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 1, 
      "_order": 0, 
      "description": "The primary outcome measure is (unassisted) patency of the AVF at ninety (90)days after surgery. This is defined as the presence of an audible bruit over the site of the arterio-venous anastomosis, without the need for surgical or radiological intervention from the time of creation until the time of assessment.\r\nThe assessment of patency will be made at this time even if the AVF is not yet used for haemodialysis (11). Measurement of bruit will also be taken at 1 month to better define the natural history of thrombotic events.", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 3, 
      "_order": 0, 
      "description": "Left Ventricular Ejection Fraction (LVEF). Timepoint: Before and after CABG. Method of measurement: Trans Thoracic Echocardiography (TTE)", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 0, 
      "description": "(This trial has no primary outcome, all outcomes are of equal weight) Acute success (clinical device and clinical procedure). Acute Success is classified according to the following definitions: Clinical Device Success Successful delivery and deployment of the Clinical Investigation stent at the target lesion and successful withdrawal of the stent delivery system with attainment of final residual stenosis < 50% by Qualitative Coronary Angiography (QCA) (by visual estimation if QCA is unavailable). Standard pre-dilation catheters and post-dilatation catheters (if applicable) may be used. Bailout subjects will be included as device success only if the above criteria for clinical device success are met. Clinical Procedure Success Successful delivery and deployment of the Clinical Investigation stent at the target lesion and successful withdrawal of the stent delivery system with attainment of final residual stenosis of < 50% by QCA (by visual estimation if QCA unavailable) and/or using any adjunctive device without the occurrence of ischemia driven major adverse cardiac event (MACE) during the hospital stay with a maximum of first seven days post index procedure. In a dual lesion setting both lesions must meet clinical procedure success. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 36, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 24, 
      "_order": 0, 
      "description": "Effect of treatment on the nominal change in percent atheroma volume of the identified target coronary artery segment from baseline after 18 months of treatment as measured by intravascular ultrasound (IVUS) imaging of the coronary arteries.", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 38, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 23, 
      "_order": 0, 
      "description": "pain relief", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 42, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 26, 
      "_order": 0, 
      "description": "The first occurrence of any of the following clinically significant outcomes: \r\ndeath\r\ncardiac arrest, requiring defibrillator or cardioversion\r\ndocumented sustained ventricular tachycardia requiring cardioversion\r\nnew development of symptomatic congestive heart failure\r\n#pacemaker or implantable cardiac defibrillator implantation\r\nstroke or any other thromboembolic event in patients with no prior thromboembolic phenomena", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 44, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 28, 
      "_order": 0, 
      "description": "Prospective investigator-blinded study involving 25 adult male and female subjects with vitiligo on the backs of both hands. Punch minigrafting will be performed on both hands taking skin from the thighs and/or buttocks. Light treatments will be administered starting at week one after grafting. One hand will receive narrow-band ultraviolet B light and the other will receive focal 308-nm light treatments. Light treatments will be administered 3 times per week for 12 weeks. A long term follow-up visit will be completed at week 25. The investigator will evaluate the subjects at week 4, 7, 13 and 25 in addition to screening and baseline evaluations/procedures.", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 46, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 29, 
      "_order": 0, 
      "description": "Incidence of preeclampsia", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 47, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 31, 
      "_order": 0, 
      "description": "proportion of patients with viral load < 80 at the end of tuberculosis therapy \r\n\r\n[Time Frame: 6 months] \r\n\r\n", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 3, 
      "_order": 1, 
      "description": "Total Antioxidant Capacity (TAC) . Timepoint: Before, middle and after CABG. Method of measurement: Biochemistry (blood sample)", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 1, 
      "_order": 1, 
      "description": "Functional patency at 6 months. This is defined as the ability to use the AVF for a minimum of 3 consecutive dialysis treatments to the satisfaction of the clinician(s), without the need to use alternative dialysis access, or to delay commencement of dialysis. In patients who have not needed to start dialysis,\r\nassessment of functional patency will be delayed until commencement of dialysis. ", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 1, 
      "description": "Cardiac Death (CD): Any death due to proximate cardiac cause (e.g., myocardial infarction, low-output failure, fatal arrhythmia), unwitnessed death, death of unknown cause, and all procedure-related deaths, including those related to concomitant treatment. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 37, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 24, 
      "_order": 1, 
      "description": "    * Compare the effect of pioglitazone HCl and glimepiride on the nominal change in total atheroma volume \r\n    * Compare the effect of pioglitazone HCl and glimepiride on the occurrence of cardiovascular events as a composite of cardiovascular mortality, nonfatal myocardial infarction, nonfatal stroke. ", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 39, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 23, 
      "_order": 1, 
      "description": "quality of life", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 43, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 26, 
      "_order": 1, 
      "description": "New development of any of the following echo changes clinically indicated or done for the trial: \r\nventricular aneurysm\r\nreduction in left ventricular (LV) ejection fraction > 5%\r\nincrease in left ventricular diastolic dysfunction (LVDD) > 5.0 mm compared with baseline\r\nProgression of New York Heart Association (NYHA) functional class by at least one category\r\nEvaluation of safety (adverse events: dermatitis, peripheral neuropathy, gastro-intestinal intolerance, leucopenia [2500 x 10^9 L]), tolerance and adherence to treatment", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 45, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 28, 
      "_order": 1, 
      "description": "Percent repigmentation of individual surviving grafts, percent repigmentation of all surviving grafts per hand, and percent repigmentation of lesional skin with each light source. Time Frame: 25 weeks", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 48, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 31, 
      "_order": 1, 
      "description": "proportion of adverse events in each group \r\n\r\n[Time Frame: 6 months] ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 1, 
      "_order": 2, 
      "description": "Time to failure of primary patency. Time from AVF creation to need for first intervention. An event is defined as revision surgery, need for alternative access, or abandonment of AVF which ever comes first. Censored observations are defined as regaining renal function such that dialysis is not needed or still having a patent AVF at time of study analysis. There will be a minimum of 12 months follow up time for each patient. ", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 2, 
      "description": "Myocardial Infarction (MI): Q wave MI Development of new, pathological Q wave on the Electrocardiogram (ECG) Non-Q wave MI Elevation of Creatine Kinase (CK) levels to greater than or equal to two times the upper limit of normal (ULN) with elevated Creatine Kinase-Myocardial Band (CK-MB) in the absence of new pathological Q waves. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 40, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 23, 
      "_order": 2, 
      "description": "1", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 49, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 31, 
      "_order": 2, 
      "description": "Immunologic reconstitution \r\n\r\n[Time Frame: 6 months]", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 1, 
      "_order": 3, 
      "description": "Time to failure of assisted patency. This is defined as time from AVF creation to abandonment of access. That is, radiological and surgical interventions to preserve or restore patency do not constitute failure. An event is defined as abandonment of the AVF as dialysis access. Censored observations will be as for time to failure of primary patency above. ", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 3, 
      "description": "Target Vessel Myocardial Infarction (TV-MI): Please see \"MI\" in outcome #2. An MI which originates in the target vessel (vessel to be treated) based on information entered by site personnel. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 41, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 23, 
      "_order": 3, 
      "description": "1", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 50, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 31, 
      "_order": 3, 
      "description": "Genotyping resistance\r\n\r\n[Time Frame: 6 months]", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 1, 
      "_order": 4, 
      "description": "Adverse events. All serious adverse events (see section 5.4) will be collected. The analysis of this secondary outcome will focus specifically on bleeding events.", 
      "interest": "secondary"
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 4, 
      "description": "Ischemia Driven Major Adverse Cardiac Events (ID MACE): The composite endpoint composed of cardiac death, myocardial infarction (MI) ischemia-driven target lesion revascularization (TLR) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 5, 
      "description": "Ischemia driven Target Vessel Failure (ID TVF): Any repeat percutaneous intervention or surgical bypass of any segment of the target vessel. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 6, 
      "description": "Ischemia Driven Target Lesion Revascularization (ID TLR): Any repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 7, 
      "description": "Ischemia Driven Target Vessel Revascularization (ID TVR): Any repeat percutaneous intervention or surgical bypass of any segment of the target vessel. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 8, 
      "description": "Stent thrombosis: Clinical presentation of acute coronary syndrome with angiographic evidence of stent thrombosis. In the absence of angiography, any unexplained death, or acute MI in the distribution of the target lesion within 30 days This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 9, 
      "description": "Descriptive analysis of strut, lesion and vessel morphology post-procedure by Optical Coherence Tomography (OCT), which is a catheter based optical imaging modality used in Percutaneous Coronary Intervention (PCI). This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 10, 
      "description": "Stent area post-procedure assessed by Optical Coherence Tomography (OCT), which is a catheter based optical imaging modality used in PCI. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 11, 
      "description": "Lumen area assessed by Optical Coherence Tomography (OCT), which is a catheter based optical imaging modality used in PCI. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 12, 
      "description": "Minimum luminal area (MLA) assessed by Optical Coherence Tomography (OCT), which is a catheter based optical imaging modality used in PCI. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 13, 
      "description": "Incomplete apposition (baseline), persisting incomplete apposition, late incomplete apposition assessed by Optical Coherence Tomography (OCT), which is a catheter based optical imaging modality used in PCI. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 14, 
      "description": "In-stent Late Loss (LL) assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 15, 
      "description": "In-segment LL assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 16, 
      "description": "Proximal LL (proximal defined as within 5 mm of tissue proximal to stent placement) assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 17, 
      "description": "Distal LL (distal defined as within 5 mm of tissue distal to stent placement) assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 18, 
      "description": "In-stent and in-segment Minimum Luminal Diameter (MLD) assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 19, 
      "description": "In-stent and in-segment % Diameter Stenosis (DS) assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 20, 
      "description": "In-stent and in-segment Angiographic Binary Restenosis (ABR) rate assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 21, 
      "description": "Aneurysm, thrombus, persisting dissection assessed by Angiography done for patients within the OCT subgroup. This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 22, 
      "description": "Vessel area assessed by Intravscular Ultrasound (IVUS) done for patients within the OCT subgroup. (IVUS is a catheter based ultrasound imaging modality used in PCI.) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 23, 
      "description": "Stent area post-procedure and (if analyzable) assessed by Intravscular Ultrasound (IVUS) done for patients within the OCT subgroup. (IVUS is a catheter based ultrasound imaging modality used in PCI.) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 32, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 24, 
      "description": "Minimum luminal area (MLA) assessed by Intravscular Ultrasound (IVUS) done for patients within the OCT subgroup. (IVUS is a catheter based ultrasound imaging modality used in PCI.) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 33, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 25, 
      "description": "In-stent %Volume Obstruction (VO) assessed by Intravscular Ultrasound (IVUS) done for patients within the OCT subgroup. (IVUS is a catheter based ultrasound imaging modality used in PCI.) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 34, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 26, 
      "description": "Incomplete apposition (baseline), persisting incomplete apposition, late incomplete apposition assessed by Intravscular Ultrasound (IVUS) done for patients within the OCT subgroup. (IVUS is a catheter based ultrasound imaging modality used in PCI.) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 35, 
    "model": "repository.outcome", 
    "fields": {
      "trial": 4, 
      "_order": 27, 
      "description": "Descriptive analysis of vascular and stent morphology using Multi-Slice Computed Tomography (MSCT) This data is entered into electronic case report forms by investigational site personnel, personal information is kept confidential. ", 
      "interest": "primary"
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Teste do Luciano em 14 de jun de 2010", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-20 20:08:49", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-14 17:48:11", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 16, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Anti-retroviral Efficacy, Tolerance and Other Pharmacologic Interactions of the Non Nucleoside Analog Efavirenz in Association With Rifampicin to Treat Tuberculosis and AIDS", 
      "public_title": "Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (IPEC-EFV)", 
      "enrollment_end_actual": null, 
      "trial_id": "RBR-9rm-tzr", 
      "inclusion_criteria": "* Adults with tuberculosis diagnosis, HIV positive.\r\n\r\n* Agreement to avoid not allowed drugs during the trial, agreement to participate in the study (informed consent)\r\n", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": false, 
      "agemin_unit": "Y", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "Tuberculosis\r\nHIV Infections", 
      "masking": [
        "open"
      ], 
      "exported": null, 
      "number_of_arms": 2, 
      "status": "published", 
      "updated": "2010-07-20 15:32:17", 
      "target_sample_size": 178, 
      "study_type": null, 
      "i_freetext": "efavirenz", 
      "acronym_expansion": "", 
      "enrollment_start_actual": null, 
      "enrollment_end_planned": null, 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "4"
      ], 
      "date_registration": null, 
      "agemin_value": 18, 
      "enrollment_start_planned": "2010-10-01", 
      "staff_note": "", 
      "study_design": "Study Type:  \t Interventional\r\n\r\nControl: Dose Comparison\r\nEndpoint Classification: Safety/Efficacy Study\r\n\r\nPrimary Purpose: Treatment\r\nAllocation: Randomized\r\nMasking: Open Label\r\nIntervention Model: Parallel Assignment\r\n", 
      "created": "2010-07-19 20:36:14", 
      "gender": "-", 
      "intervention_assignment": [
        "parallel"
      ], 
      "exclusion_criteria": "* Active liver disease\r\n* Pregnancy or breast feeding\r\n* CD4 counts > 350\r\n", 
      "primary_sponsor": 39, 
      "recruitment_status": [
        "pending"
      ]
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "The Efficacy of Hand-Foot Narrow-Band UVB Versus Focal 308-nm Treatment in Inducing Repigmentation of Vitiligo After Minigrafting on the Dorsal Hands", 
      "public_title": "The Efficacy of Hand NBUVB Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ], 
        [
          "US"
        ]
      ], 
      "i_code": [
        [
          "device"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": false, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "Vitiligo", 
      "masking": [
        "single-blind"
      ], 
      "exported": null, 
      "number_of_arms": 2, 
      "status": "processing", 
      "updated": "2010-07-19 17:45:50", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "Device: Daavlin Spectra UVB Hand/Foot Box Narrow-band ultraviolet B hand box\r\nDevice: Excilite Focal 308-nm light\r\n\r\nActive Comparator\r\nRight hand treated with narrow-band UVB light and left hand treated with focal 308-nm light\r\nIntervention: Device: Daavlin Spectra UVB Hand/Foot Box\r\nActive Comparator\r\nRight hand treated with focal 308-nm light and left hand treated with narrow-band UVB light\r\nIntervention: Device: Excilite Focal 308-nm light", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "1-2"
      ], 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "Allocation:  Randomized\r\nControl:  Active Control\r\nEndpoint Classification:  Safety/Efficacy Study\r\nIntervention Model:  Single Group Assignment\r\nMasking:  Single Blind (Investigator)\r\nPrimary Purpose:  Treatment", 
      "created": "2010-07-07 12:47:53", 
      "gender": "-", 
      "intervention_assignment": [
        "single-group"
      ], 
      "exclusion_criteria": "", 
      "primary_sponsor": 34, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Title10\r\na\r\nb\r\nc\r\n3\r\n3\r\n\r\n2\r\n\r\n3\r\n3\r\n4", 
      "public_title": "", 
      "enrollment_end_actual": null, 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-19 14:35:33", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": null, 
      "enrollment_end_planned": null, 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": null, 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-07-16 19:32:32", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 37, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Teste 30/jun", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-16 13:35:33", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-30 13:27:51", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 33, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "A randomised, double-blind, placebo-controlled, factorial-design trial to assess the effect of aspirin and fish oil in the prevention of early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "1. Stage 4 or 5 chronic kidney disease\r\n2. Currently on haemodialysis or haemodialysis is planned to start within 6\r\nmonths (including patients currently on peritoneal dialysis).\r\n3. Planned AVF will be the primary haemodialysis access mechanism.\r\n4. Surgery to create an arterio-venous fistula in the upper or lower arm is planned.\r\n5. Aged over 18 years\r\n6. Life expectancy predicted to be 12 months minimum\r\n7. Treating team agreeable to patient\\'s involvement in the trial\r\n8. Informed consent ", 
      "recruitment_country": [
        [
          "AW"
        ], 
        [
          "NZ"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ], 
        [
          "dietary supplement"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "Y", 
      "scientific_acronym": "FAVOURED (Fish oil and Aspirin in Vascular acccess OUtcomes in REnal Disease)", 
      "acronym": "", 
      "hc_freetext": "Early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis.", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 17:00:13", 
      "target_sample_size": 1200, 
      "study_type": [
        "interventional"
      ], 
      "i_freetext": "Aspirin 100 mg per day or matching placebo, commencing on the day prior to scheduled surgery and continuing for 3 months.", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": [
        "1"
      ], 
      "date_registration": null, 
      "agemin_value": 18, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-01-20 17:47:08", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "1. Revision of existing AVF rather than de novo AVF\r\n2. Medical indication for anti-platelet agent(s)\r\n3. Known intolerance of agents including hypersensitivity to aspirin\r\n4. Current use of aspirin within two weeks of commencing trial, and of fish oil within 4 weeks of commencing trial.\r\n5. Pregnancy, lactation or intention to fall pregnant during the time course of the study\r\n6. Known bleeding disorder or established diagnosis of active or suspected bleeding\r\n7. Known active peptic ulcer disease\r\n8. Already receiving anti-coagulation therapy such as warfarin\r\n9. Receiving regular anti-inflammatory agents for another indication such as\r\narthritis\r\n10.Potential non-compliance with treatment regimen in the view of the\r\ntreating clinicians\r\n11.Involved in another clinical trial where the intervention being trialled is likely to confound the outcome of this trial\r\n12.Previously randomised to this trial. ", 
      "primary_sponsor": 1, 
      "recruitment_status": [
        "pending"
      ]
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Minimal trial record (only required fields)", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:58:49", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-01-20 17:47:08", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": null, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Effect of Ascorbic Acid and Grape Seed Extract \"Vitis Vinifera L.\" on Oxidative Stress Induced by on Pump Coronary Artery bypass Grafting Surgery", 
      "public_title": "Comparison of Ascorbic Acid and Grape Seed Extract in Oxidative Stress Induced by on Pump Heart Surgery", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "Candidates for elective CABG surgery with pump for first time, 3 Vessel Disease (3VD).", 
      "recruitment_country": [
        [
          "IR"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "Condition 1: Coronary Atrery Bypass Graft (CABG).\r\nCondition 2: Atherosclerotic heart disease.\r\nCondition 3: Ischaemic cardiomyopathy.", 
      "masking": [
        "double-blind"
      ], 
      "exported": null, 
      "number_of_arms": 3, 
      "status": "processing", 
      "updated": "2010-07-15 16:57:56", 
      "target_sample_size": 75, 
      "study_type": [
        "interventional"
      ], 
      "i_freetext": "Intervention 1: Control Group: without intervention.\r\nIntervention 2: Grape Seed Extract 100 mg/6h .\r\nIntervention 3: Vit C 25 mg/kg.", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "2-3"
      ], 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "2008-11-01", 
      "staff_note": "", 
      "study_design": "Randomization: randomized. Blinding: Double blind. Placebo: not used. Assignment: Parallel. Purpose: Supportive care. Other design features: .", 
      "created": "2010-01-20 17:47:08", 
      "gender": "-", 
      "intervention_assignment": [
        "parallel"
      ], 
      "exclusion_criteria": "High risk patients, Those who need another heart surgery beside CABG, Urgent patients Diabetics, Ischemic time more than 120 min.", 
      "primary_sponsor": 2, 
      "recruitment_status": [
        "completed"
      ]
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Clinical Investigation: A Continuation in the Clinical Evaluation of the Bioabsorbable Vascular Solutions (BVS) Everolimus Eluting Coronary Stent System (EECCS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions  ", 
      "public_title": "Clinical Investigation: An assessment of the safety and performance of the Bioabsorbable Vascular Solutions (BVS) Everolimus Eluting Coronary Stent System (EECCS) in the treatment of patients with de novo native coronary artery lesions.", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "Up to two de novo lesions can be treated, each located in a separate native epicardial vessel.\r\n\r\nTarget lesion(s) must measure <= 28 mm in length by Qualitative Coronary Angiography (QCA), or by visual estimation if on line QCA is not available.\r\n\r\nTarget lesion(s) must be in a major artery or branch with a visually estimated stenosis of >= 50% and < 100% with a Thrombolysis in Myocardial Infarction (TIMI) flow of >= 1.\r\n\r\nIf two treatable lesions meet the inclusion criteria they must be in separate major epicardial vessels.\r\n\r\nPercutaneous interventions for lesions in a non-target vessel are allowed if done >= 30 days prior to or if planned to be done > 6 months after the index procedure.\r\n\r\nPercutaneous intervention for lesions in the target vessel are allowed if done > 6 months prior to or if planned to be done 6 months after the index procedure.", 
      "recruitment_country": [
        [
          "AU"
        ], 
        [
          "BE"
        ], 
        [
          "BR"
        ], 
        [
          "DK"
        ], 
        [
          "FR"
        ], 
        [
          "IT"
        ], 
        [
          "NL"
        ], 
        [
          "PL"
        ], 
        [
          "CH"
        ]
      ], 
      "i_code": [
        [
          "device"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "Y", 
      "scientific_acronym": "ABSORB EXTEND", 
      "acronym": "ABSORB EXTEND", 
      "hc_freetext": "Coronary Artery Stenosis\r\nCoronary Disease\r\nCoronary Artery Disease\r\n", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:52:06", 
      "target_sample_size": 1000, 
      "study_type": null, 
      "i_freetext": "Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS). Percutaneous Coronary Intervention (PCI) is commonly known as coronary angioplasty. Typically, PCI is performed by threading a slender balloon-tipped tube, a catheter, from an artery in the groin to a trouble spot in an artery of the heart. The balloon is then inflated, compressing the plaque and dilating (widening) the narrowed coronary artery so that blood can flow more easily. During PCI for this study, the BVS EECSS is then placed in the coronary artery to support the previously narrowed area. The BVS EECSS will remain in place until the bioabsorbtion process is complete, your physician will discuss this process with you. The duration of the PCI procedure will depend on many factors, and is typically less than 2 hours. Your physician will discuss those factors and the length of your procedure with you.\r\n\r\nOptical Coherence Tomography (OCT) subgroup definition:\r\n- A subgroup of up to 50 subjects who:\r\n\r\n- Have their procedures performed at selected investigational sites with OCT capability; and\r\n\r\n- Receive planned overlapping stent treatment of the target lesion.\r\n\r\n- The need for planned overlapping of BVS stents will be determined by the investigator up to the time of the index procedure.\r\n\r\n- Angiography, Intravascular Ultrasound (IVUS) and OCT are required for all subjects in the OCT subgroup post-procedure and at 2-year follow-up\r\n\r\n\r\n\r\nMulti-Slice Computed Tomography subgroup definition:\r\n\r\n- A subgroup of up to 100 subjects who:\r\n\r\n- Have their procedures performed at selected investigational sites having both OCT and MSCT capability; and\r\n\r\n- Receive at least one BVS EECSS in the target lesion.\r\n\r\nMSCT imaging and clinical follow-up at 18 months is required for all subjects in the MSCT subgroup.", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 18, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-03-02 13:34:30", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "Lesion(s) located within an arterial or saphenous vein graft or distal to a diseased (defined as vessel irregularity per angiogram and > 20% stenosed lesion by visual estimation) arterial or saphenous vein graft. Lesion(s) involving a bifurcation with side branch vessel >= 2 mm in diameter, ostial lesion > 40% stenosed by visual estimation or side branch requiring predilatation. Total occlusion (TIMI flow 0), prior to wire passing. Target vessel(s) contains visible thrombus. Another clinically significant lesion is located in the same epicardial vessel (including side branch) as the target lesion(s). Subject has received brachytherapy in any epicardial vessel (including side branches).", 
      "primary_sponsor": 3, 
      "recruitment_status": [
        "recruiting"
      ]
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "teste de Margot", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:44:19", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-04-05 16:56:59", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 5, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Avalia\u00e7\u00e3o da dosagem do praziquantel para o tratamento da esquistossomose no Brasil", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:42:49", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-04-22 13:18:47", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 6, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "NL"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:42:30", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-04-22 19:17:28", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 7, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "The efficacy of penicillin G potassium in reducing aphthous ulcer pain and lesion size in a Chinese cohort: a randomized, double-blinded, placebo and blank controlled, multicenter clinical trial.", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "CN"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-15 16:41:00", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-04-22 20:01:45", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 8, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": false, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-13 19:19:26", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": [
        "3"
      ], 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-07-13 19:07:15", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 36, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Benznidazole evaluation for interrupting tripanosomiasis \u2013 BENEFIT trial", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "Consenting patients (between 18 and 75 years of age) with serological evidence of Chagas infection (any combination of 2 positive tests) and that have one or more of the following:\r\nAbnormal electrocardiogram with at least two components (complete RBBB or LBBB; left anterior or posterior fascicular block; ventricular premature beat; first degree atrioventricular [AV] block; Mobitz type I AV block; sinus bradycardia; primary ST-T changes; abnormal Q waves; low voltage QRS; or atrial fibrillation);\r\nAbnormal ECG (Mobitz type II, advanced or third degree AV block)", 
      "recruitment_country": [
        [
          "AR"
        ], 
        [
          "BR"
        ], 
        [
          "CA"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 75, 
      "agemax_unit": "Y", 
      "expanded_access_program": false, 
      "agemin_unit": "Y", 
      "scientific_acronym": "BENEFIT", 
      "acronym": "", 
      "hc_freetext": "Chagas Disease\r\nTrypanosomiasis\r\nHeart Disease\r\n", 
      "masking": [
        "double-blind"
      ], 
      "exported": null, 
      "number_of_arms": 1, 
      "status": "processing", 
      "updated": "2010-07-07 14:17:55", 
      "target_sample_size": 600, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "Benznidazole Evaluation for Interrupting Trypanosomiasis", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "1-2"
      ], 
      "date_registration": null, 
      "agemin_value": 18, 
      "enrollment_start_planned": "2004-01-11", 
      "staff_note": "", 
      "study_design": "Double-Blind, randomized placebo control safety and efficacy study with single Group Assignment for treatment os Chagas Disease", 
      "created": "2010-06-30 11:25:32", 
      "gender": "-", 
      "intervention_assignment": [
        "single-group"
      ], 
      "exclusion_criteria": "NYHA heart failure class IV or decompensated heart failure\r\nEvidence of concomitant coronary artery disease (CAD) or other etiology of dilated cardiomyopathy\r\nPrevious treatment with antitrypanosomal agents or an accepted indication for antiparasitic therapy\r\nHistory of severe alcohol abuse within 2 years\r\nKnown chronic renal or hepatic insufficiency\r\nPregnancy or breast feeding\r\n", 
      "primary_sponsor": 32, 
      "recruitment_status": [
        "recruiting"
      ]
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "title scientific test", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-07-01 13:53:07", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-29 14:08:33", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 30, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus (PERISCOPE)", 
      "public_title": "Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus", 
      "enrollment_end_actual": "", 
      "trial_id": "RBR-7k3-rct", 
      "inclusion_criteria": "nclusion Criteria:\r\n\r\n    * Females of childbearing potential who were sexually active agreed to use adequate ontraception, and can neither be pregnant nor lactating from screening throughout the duration of the study.\r\n    * Had a diagnosis of type 2 diabetes mellitus\r\n    * Have received appropriate counseling on lifestyle modification for type 2 diabetes, including diet and exercise.\r\n    * na\u00efve to or was not currently taking antidiabetic therapy\r\n    * Had a glycosylated hemoglobin level greater than or equal to 6.0% and less than 9% at screening if taking antidiabetic medication", 
      "recruitment_country": [
        [
          "BR"
        ], 
        [
          "CA"
        ], 
        [
          "CL"
        ], 
        [
          "US"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ]
      ], 
      "agemax_value": 85, 
      "agemax_unit": "Y", 
      "expanded_access_program": false, 
      "agemin_unit": "Y", 
      "scientific_acronym": "PERISCOPE", 
      "acronym": "", 
      "hc_freetext": "Diabetes mellitus", 
      "masking": [
        "double-blind"
      ], 
      "exported": null, 
      "number_of_arms": 2, 
      "status": "published", 
      "updated": "2010-06-22 14:19:04", 
      "target_sample_size": 544, 
      "study_type": null, 
      "i_freetext": "    * Drug: Pioglitazone\r\n      Up to 45 mg pioglitazone (optimized for glucose control), tablets, orally, once daily for up to 72 weeks.\r\n      Other Names: ACTOS\u00ae, AD4833\r\n    * Drug: Glimepiride\r\n      Up to 4 mg of glimepiride (optimized for glucose control), tablets, orally, once daily for up to 72 weeks.\r\n", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "3"
      ], 
      "date_registration": null, 
      "agemin_value": 35, 
      "enrollment_start_planned": "2010-01-07", 
      "staff_note": "", 
      "study_design": "A Double-Blind, Randomized, parallel phase III Study", 
      "created": "2010-06-22 10:41:42", 
      "gender": "-", 
      "intervention_assignment": [
        "parallel"
      ], 
      "exclusion_criteria": "Exclusion Criteria:\r\n\r\n    * Had type I diabetes mellitus.\r\n    * Had participated in another investigational study, or participated in an investigational study 30 days prior to the start of this study\r\n    * Male subjects who had a serum creatinine level greater than or equal to 2.0 mg/dL ", 
      "primary_sponsor": 28, 
      "recruitment_status": [
        "pending"
      ]
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "t\u00edtulo em ingl\u00eas", 
      "public_title": "asdf", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "AM"
        ], 
        [
          "AU"
        ], 
        [
          "BZ"
        ], 
        [
          "BT"
        ]
      ], 
      "i_code": [
        [
          "drug"
        ]
      ], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": false, 
      "agemin_unit": "-", 
      "scientific_acronym": "as3", 
      "acronym": "2342", 
      "hc_freetext": "", 
      "masking": [
        "double-blind"
      ], 
      "exported": null, 
      "number_of_arms": 3, 
      "status": "processing", 
      "updated": "2010-06-22 12:46:59", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "342", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": [
        "randomized-controlled"
      ], 
      "scientific_acronym_expansion": "2434", 
      "purpose": [
        "treatment"
      ], 
      "phase": [
        "3"
      ], 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "randomized controlled trial\r\n", 
      "created": "2010-06-21 21:26:44", 
      "gender": "-", 
      "intervention_assignment": [
        "parallel"
      ], 
      "exclusion_criteria": "", 
      "primary_sponsor": 27, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "\u201cEstudo TEAM (Efic\u00e1cia do Tasigna em Melanoma Avan\u00e7ado): Estudo fase III, de dois bra\u00e7os, randomizado, aberto e multic\u00eantrico para comparar a efic\u00e1cia de Tasigna\u00ae versus dacarbazina (DTIC) no tratamento de pacientes com melanoma metast\u00e1tico e/ou inoper\u00e1vel contendo uma muta\u00e7\u00e3o do c-Kit\u201d", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-21 20:53:31", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-21 20:35:22", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 26, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "teste", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "AF"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-21 13:55:07", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-21 13:55:07", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 25, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma (EXPECT)", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "AU"
        ], 
        [
          "BE"
        ], 
        [
          "FR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "(EXPECT)", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-18 19:53:13", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-18 19:16:12", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 22, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "hghjghjghjhj", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "AT"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-17 19:26:29", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-17 19:26:29", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 21, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "fdfdfdfdf", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-17 19:23:02", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-17 19:23:02", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 20, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Segundo teste do dia 17/06", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-17 17:48:22", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-17 17:48:22", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 19, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Teste do dia 17/06", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-17 17:47:04", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-17 17:47:04", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 18, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "My new clinical trial", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-15 23:27:39", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-15 23:27:27", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 17, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Demo do dia 14 de junho", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": "RBR-46w-jsc", 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "published", 
      "updated": "2010-06-14 13:55:51", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-14 13:40:25", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 14, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Uso da metformina em pacientes com diabetes tipo 2", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "AF"
        ], 
        [
          "AO"
        ], 
        [
          "BD"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-14 13:44:50", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-14 13:44:50", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 15, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "T\u00edtulo A", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "UG"
        ], 
        [
          "AE"
        ], 
        [
          "UY"
        ], 
        [
          "VU"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-14 13:00:40", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-14 13:00:40", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 10, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "06/12/2010 Test", 
      "public_title": "06/12/2010 Test", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "BR"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "Test", 
      "acronym": "Teste", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-06-12 20:51:27", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "test", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "Test", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-06-12 20:47:20", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 9, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.clinicaltrial", 
    "fields": {
      "scientific_title": "Teste da reuni\u00e3o Elluminate", 
      "public_title": "", 
      "enrollment_end_actual": "", 
      "trial_id": null, 
      "inclusion_criteria": "", 
      "recruitment_country": [
        [
          "DZ"
        ], 
        [
          "AO"
        ], 
        [
          "AW"
        ]
      ], 
      "i_code": [], 
      "agemax_value": 0, 
      "agemax_unit": "-", 
      "expanded_access_program": null, 
      "agemin_unit": "-", 
      "scientific_acronym": "", 
      "acronym": "", 
      "hc_freetext": "", 
      "masking": null, 
      "exported": null, 
      "number_of_arms": null, 
      "status": "processing", 
      "updated": "2010-03-30 18:55:44", 
      "target_sample_size": 0, 
      "study_type": null, 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "enrollment_start_actual": "", 
      "enrollment_end_planned": "", 
      "allocation": null, 
      "scientific_acronym_expansion": "", 
      "purpose": null, 
      "phase": null, 
      "date_registration": null, 
      "agemin_value": 0, 
      "enrollment_start_planned": "", 
      "staff_note": "", 
      "study_design": "", 
      "created": "2010-03-30 18:51:44", 
      "gender": "-", 
      "intervention_assignment": null, 
      "exclusion_criteria": "", 
      "primary_sponsor": 4, 
      "recruitment_status": null
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Efeito do \u00e1cido asc\u00f3rbico e extrato de semente de Uva \"Vitis Vinifera L.\" sobre o estresse oxidativo induzido por bomba em cirurgia de revasculariza\u00e7\u00e3o de art\u00e9ria coronariana", 
      "study_design": "", 
      "hc_freetext": "Condi\u00e7\u00e3o 1: cirurgia de revasculariza\u00e7\u00e3o de art\u00e9ria (RM).\r\nCondi\u00e7\u00e3o 2: doen\u00e7a card\u00edaca ateroscler\u00f3tica.\r\nCondi\u00e7\u00e3o 3: cardiomiopatia isqu\u00eamica.", 
      "language": "pt-BR", 
      "public_title": "Compara\u00e7\u00e3o de \u00e1cido asc\u00f3rbico e Extrato de Semente de Uva no estresse oxidativo induzido pela cirurgia card\u00edaca com bomba", 
      "i_freetext": "Interven\u00e7\u00e3o 1: Grupo controle: sem interven\u00e7\u00e3o.\r\nInterven\u00e7\u00e3o 2: Extrato de semente de uva 100 mg/6h.\r\nInterven\u00e7\u00e3o 3: Vit C 25 mg / kg.", 
      "acronym_expansion": "", 
      "object_id": 3, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "Candidatos a cirurgia de revasculariza\u00e7\u00e3o mioc\u00e1rdica eletiva, com bomba pela primeira vez, doen\u00e7a dos tr\u00eas vasos (3VD).", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": "Pacientes de alto risco; aqueles que necessitam de outra cirurgia card\u00edaca al\u00e9m de RM; pacientes de urg\u00eancia; diab\u00e9ticos; tempo de isquemia superior a 120 min"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "en", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 10, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Teste de 12/06/2010", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "Teste de 12/06/2010", 
      "i_freetext": "", 
      "acronym_expansion": "teste", 
      "object_id": 10, 
      "scientific_acronym": "Teste", 
      "acronym": "Teste", 
      "scientific_acronym_expansion": "Teste", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 10, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "en", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 15, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 15, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 15, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "en", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 20, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "estudo fase II de lenalidomide monodroga em sujeitos com relapso ou linfoma refrat\u00e1rio de c\u00e9lulas T n\u00e3o-hodgkin", 
      "study_design": "", 
      "hc_freetext": "cefal\u00e9ia", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 20, 
      "scientific_acronym": "(EXPECT)", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 20, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 22, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "A popula\u00e7\u00e3o-alvo compreende pacientes adultos com melanoma irressec\u00e1vel ou metast\u00e1tico com muta\u00e7\u00e3o no c-Kit que n\u00e3o receberam terapia anterior com TKIs.", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 22, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 23, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "t\u00edtulo em portugu\u00eas", 
      "study_design": "ensaio cl\u00ednico controlado randomizado", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "medicamento bevacizumabe 50mg comprimidos orais", 
      "acronym_expansion": "", 
      "object_id": 23, 
      "scientific_acronym": "TEP", 
      "acronym": "", 
      "scientific_acronym_expansion": "T\u00edtulo Em Portug\u00eas", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 24, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Estudo de efic\u00e1cia da Plioglitazona comparada com a Glimeopirida na progress\u00e3o da doen\u00e7a ateroscler\u00f3tica coronariana em pessoas com diabetes mellitus tipo 2 (PERISCOPE)", 
      "study_design": "Ensaio cl\u00ednico duplo-cego, randomizado, paralelo, fase 3  ", 
      "hc_freetext": "Diabetes mellitus", 
      "language": "pt-br", 
      "public_title": "Estudo de efic\u00e1cia da Plioglitazona comparada com a Glimeopirida na progress\u00e3o da doen\u00e7a ateroscler\u00f3tica coronariana em pessoas com diabetes mellitus tipo 2 ", 
      "i_freetext": "Droga: pioglitazona\r\n Dose: at\u00e9 45 mg de plioglitazona (otimizada para controle da glicose), comprimidos, via oral, uma vez ao dia at\u00e9 72 semanas\r\nOutros nomes:ACTOS\u00ae, AD4833\r\nDroga; Glimerpirida\r\n Dose: at\u00e9 4 mg de glimepirida (otimizada para controle da glicose) , comprimidos, via oral, uam vez ao dia at\u00e9 72 semanas", 
      "acronym_expansion": "", 
      "object_id": 24, 
      "scientific_acronym": "PERISCOPE", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "Crit\u00e9rios de inclus\u00e3o:\r\n * Mulehres com potencial para procria\u00e7\u00e3o que s\u00e3o sexualmente ativas e concordaram com uso de contracep\u00e7\u00e3o adequada e n\u00e3o podem estar gr\u00e1vidas ou em lacta\u00e7\u00e3o desde o rastreamento e ao longo do estudo\r\n * Ter tido diagn\u00f3stico de diabetes tipo 2\r\n * Ter recebido aconselhamento apropriado de modifica\u00e7\u00e3o do estilo de vida para diabetes tipo 2, incluindo dieta e exerc\u00edcio.\r\n * nunca ter se tratado ou n\u00e3o estar atualmente em terapia antidiab\u00e9tica\r\n * ter n\u00edvel d ehemoglobina glicosada maior ou igual a 6% e menor que 9% no rastramento se estiver tomando medica\u00e7\u00e3o para diabetes", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": "Crit\u00e9rios de exclus\u00e3o:\r\n\r\n * Ter diabetes mellitus tipo 1\r\n * Ter participado em outro estudo investigativo nos 30 dias pr\u00e9vios ao in\u00edcio deste estudo\r\n * Homens com n\u00edvel de creatinina s\u00e9rica maior ou igual a 2,0 mg/dL"
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 26, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Avalia\u00e7\u00e3o do Benznidazol para interrup\u00e7\u00e3o da tripanosom\u00edase \u2013 ensaio BENEFIT", 
      "study_design": "Estudo de seguran\u00e7a e efic\u00e1cia duplo-cego, randomizado, controlado para placebo com bra\u00e7o \u00fanico para tratamento da Doen\u00e7a de Chagas", 
      "hc_freetext": "Doen\u00e7a de Chagas\r\nTripanosom\u00edase\r\nDoen\u00e7a card\u00edaca", 
      "language": "pt-br", 
      "public_title": "Ensaio BENEFIT: avalia\u00e7\u00e3o do use de droga antiparasit\u00e1ria (Benznidazol no tratamento da forma cr\u00f4nica da Doen\u00e7a de Chagas", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 26, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "Pacientes com idade entre 18 e 75 anos com evid\u00eancia sorol\u00f3gica de infec\u00e7\u00e3o por Chagas (qualquer combina\u00e7\u00e3o de 2 testes positivos) e que tenha uma ou mais das seguintes condi\u00e7\u00f5es:\r\nEletrocardiograma anormal com no m\u00ednimo dois componentes (bloqueio completo do ramo direito, bloqueio divisional \u00e2ntero-superior esquerdo, altera\u00e7\u00e3o da repolariza\u00e7\u00e3o inferolateral e sobrecarga ventricular esquerda, bradicardia sinusal e fibrila\u00e7\u00e3o atrial);\r\nECG anormal (Mobitz tipo II, bloqueio AV avan\u00e7ado ou de terceiro grau)", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": "Insufici\u00eancia card\u00edaca n\u00e3o-compensada ou insuficiencia card\u00edaca classe IV (NYHA)\r\nEvid\u00eancia de doen\u00e7a cardio-coronariana concomitante ou outra etiologia de miocardiopatia\r\nTratamento pr\u00e9vio com agentes antitripanosomiais ou indica\u00e7\u00e3o aceita para terapia antiparasit\u00e1ria\tHist\u00f3ria de alcoolismo grave nos \u00faltimos dois anos\r\nInsuficiencia renal ou hep\u00e1tica cr\u00f4nica\r\nGravidez ou em amamenta\u00e7\u00e3o\r\n"
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 25, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "titulo cientifico teste", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 25, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 28, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Efic\u00e1cia da luz ultravioleta B de banda estreita versus tratamento focal com 308-nm na indu\u00e7\u00e3o da repigmenta\u00e7\u00e3o do vitiligo ap\u00f3s minitransplante no dorso das m\u00e3os", 
      "study_design": "Estudo randomizado, unicego, controle ativo para avliar a seguran\u00e7a e efic\u00e1cia no tratamento do vitiligo ", 
      "hc_freetext": "Vitiligo", 
      "language": "pt-br", 
      "public_title": "Efic\u00e1cia da UVBBE de m\u00e3o versus excilite no tratamento do vitiligo ap\u00f3s minitransplante no dorso das m\u00e3os", 
      "i_freetext": "Equipamento: Daavlin Spectra M\u00e3o/P\u00e9 box manual de luz ultravioleta B de banda estreita\r\nEquipamento: luz focal 308-nm exclilite\r\nComparador ativo\r\nM\u00e3o direita tratada com luz UVB de banda estreita e m\u00e3o esquerda tratada com luz focal de 308-nm\r\nInterven\u00e7\u00e3o: equipamento Daavlin Spectra UVB caixa m\u00e3o/p\u00e9\r\nComparador ativo\r\nM\u00e3o direita tratada com luz focal de 308-nm  e m\u00e3o esquerda tratada com luz UVB de banda estreita\r\nInterven\u00e7\u00e3o: equipamento Excilite focal 308-nm", 
      "acronym_expansion": "", 
      "object_id": 28, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 29, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 29, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 27, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "T\u00edtulo cient\u00edfico", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 27, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 9, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 9, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 8, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 8, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 7, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 32, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 7, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 33, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 6, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 34, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 6, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 35, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 4, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 36, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 4, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 37, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 3, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 38, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 2, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 39, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 2, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 40, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 1, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 41, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 1, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 42, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "titulo10", 
      "study_design": "", 
      "hc_freetext": "mialgia", 
      "language": "pt-BR", 
      "public_title": "", 
      "i_freetext": "Medicamento A", 
      "acronym_expansion": "", 
      "object_id": 30, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 43, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 30, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 44, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "Efic\u00e1cia anti-retroviral, toler\u00e2ncia e outras intera\u00e7\u00f5es farmacol\u00f3gicas dos inibidores n\u00e3o nucleos\u00eddeos an\u00e1logos do efavirenz em associa\u00e7\u00e3o com a rifampicina no tratamento da tuberculose e AIDS", 
      "study_design": "", 
      "hc_freetext": "Tuberculose\r\nInfecc\u00e7\u00f5es por HIV", 
      "language": "pt-BR", 
      "public_title": "Ensaio cl\u00ednico randomizado para avaliar a efic\u00e1cia e seguran\u00e7a do uso concomitante de rifampicina e 600 X Efavirenz 800mg (EFV-IPEC)", 
      "i_freetext": "efavirenz", 
      "acronym_expansion": "", 
      "object_id": 31, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "* Adultos com diagn\u00f3stico de tuberculose, HIV positivo.\r\n\r\n* Concord\u00e2ncia para evitar as drogas n\u00e3o permitidas durante o ensaio, concord\u00e2ncia para participar do estudo (consentimento informado)", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": "* Doen\u00e7a hep\u00e1tica ativa\r\n* Gestante ou amamentando\r\n* Contagem CD4 > 350"
    }
  }, 
  {
    "pk": 45, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 31, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 46, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "es", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 14, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 47, 
    "model": "repository.clinicaltrialtranslation", 
    "fields": {
      "scientific_title": "", 
      "study_design": "", 
      "hc_freetext": "", 
      "language": "pt-br", 
      "public_title": "", 
      "i_freetext": "", 
      "acronym_expansion": "", 
      "object_id": 14, 
      "scientific_acronym": "", 
      "acronym": "", 
      "scientific_acronym_expansion": "", 
      "inclusion_criteria": "", 
      "content_type": [
        "repository", 
        "clinicaltrial"
      ], 
      "exclusion_criteria": ""
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "CRG120600100", 
      "trial": 1, 
      "issuing_authority": "CRG"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "ACTRN12607000569404", 
      "trial": 1, 
      "issuing_authority": "ANZCTR"
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00839085", 
      "trial": 3, 
      "issuing_authority": "ClinicalTrials.gov"
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "IRCT138708271460N1", 
      "trial": 3, 
      "issuing_authority": "IRCT"
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "ACTRN12610000131055", 
      "trial": 4, 
      "issuing_authority": "ANZCTR"
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT01023789 ", 
      "trial": 4, 
      "issuing_authority": "ClinicalTrials.gov"
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "134913091283901", 
      "trial": 5, 
      "issuing_authority": "ANZCTR"
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "123456", 
      "trial": 10, 
      "issuing_authority": "CONEP"
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "654321", 
      "trial": 10, 
      "issuing_authority": "UTN"
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00655668", 
      "trial": 20, 
      "issuing_authority": "clinicaltrials.gov"
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "456666", 
      "trial": 23, 
      "issuing_authority": "weg"
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "2211", 
      "trial": 23, 
      "issuing_authority": "werea"
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00225277", 
      "trial": 24, 
      "issuing_authority": "clinicaltrials.gov"
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "CDT54789", 
      "trial": 24, 
      "issuing_authority": "Comit\u00ea de \u00c9tica do Hospital Universit\u00e1rio de Bras\u00edlia"
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "32", 
      "trial": 23, 
      "issuing_authority": "23432"
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00123916", 
      "trial": 26, 
      "issuing_authority": "Clinicaltrials.gov"
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "11394", 
      "trial": 26, 
      "issuing_authority": "CONEP"
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00622180", 
      "trial": 28, 
      "issuing_authority": "Clinicaltrials.gov"
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "14792084", 
      "trial": 28, 
      "issuing_authority": "CEP Unicamp"
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "0001", 
      "trial": 30, 
      "issuing_authority": "sponsor"
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "NCT00533390", 
      "trial": 31, 
      "issuing_authority": "ClinicalTrials.gov"
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "1234.1.123.123-12", 
      "trial": 31, 
      "issuing_authority": "CONEP (CAAE)"
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.trialnumber", 
    "fields": {
      "id_number": "U1111-1111-4101", 
      "trial": 31, 
      "issuing_authority": "ICTRP/WHO (UTN)"
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 1, 
      "institution": 1
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 20, 
      "institution": 11
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 20, 
      "institution": 17
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 23, 
      "institution": 3
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 24, 
      "institution": 29
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 28, 
      "institution": 14
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.trialsecondarysponsor", 
    "fields": {
      "trial": 30, 
      "institution": 38
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 3, 
      "institution": 1
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 4, 
      "institution": 3
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 20, 
      "institution": 19
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 20, 
      "institution": 14
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 20, 
      "institution": 8
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 20, 
      "institution": 23
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 23, 
      "institution": 26
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 24, 
      "institution": 1
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.trialsupportsource", 
    "fields": {
      "trial": 28, 
      "institution": 35
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "NZ"
      ], 
      "name": "National Institute for Health Innovation", 
      "address": "School of Population Health\r\nTamaki Campus\r\nThe University of Auckland\r\nPrivate Bag 92019 \r\nAuckland Mail Centre\r\nAuckland 1142"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "IR"
      ], 
      "name": "Tabriz University of Medical Sciences", 
      "address": "Daneshgah St,Tabriz Univ Med Sci\r\nTabriz\r\nZip: 51656-65811"
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Abbott Vascular", 
      "address": ""
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "DZ"
      ], 
      "name": "Fooo", 
      "address": ""
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AU"
      ], 
      "name": "Patrocinador xyz", 
      "address": ""
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Funda\u00e7\u00e3o Oswaldo Cruz", 
      "address": ""
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "NL"
      ], 
      "name": "Radboud University ", 
      "address": ""
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "CN"
      ], 
      "name": " \tWest China Hospital, Sichuan University", 
      "address": ""
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Fiocruz", 
      "address": ""
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AT"
      ], 
      "name": "Eudgo aaaaaaaaaa. Inc.", 
      "address": ""
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Genentech, Inc.", 
      "address": ""
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Genentech, Inc.", 
      "address": "sdf"
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Genentech, Inc.", 
      "address": "sdf"
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AR"
      ], 
      "name": "ACME", 
      "address": ""
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AR"
      ], 
      "name": "ACME", 
      "address": ""
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "ACME", 
      "address": ""
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "FM Inc.", 
      "address": ""
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Minist\u00e9rio da Sa\u00fade", 
      "address": ""
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Minist\u00e9rio da Sa\u00fade", 
      "address": ""
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Ministerio", 
      "address": ""
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AT"
      ], 
      "name": "teste", 
      "address": ""
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Celgene Corporation", 
      "address": ""
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "GB"
      ], 
      "name": "Jumperkraft", 
      "address": "Heal Highway, 311\r\nPO 3WWWEQ"
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Klintban", 
      "address": "av. norte, sn\r\nvlia dos alpes\r\n"
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BS"
      ], 
      "name": "tete", 
      "address": ""
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "CH"
      ], 
      "name": "Novartis", 
      "address": ""
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Clyde corp.", 
      "address": ""
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Takeda Research Group", 
      "address": ""
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "National Diabetes Association", 
      "address": "1340 W Street, Auckland California 13900"
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "FIOCRUZ", 
      "address": ""
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "TESTE", 
      "address": "DKFA ~KF ASKLF \u00c3LKsdf "
    }
  }, 
  {
    "pk": 32, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "CA"
      ], 
      "name": "Hamilton health Sciences", 
      "address": ""
    }
  }, 
  {
    "pk": 33, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "ACME", 
      "address": ""
    }
  }, 
  {
    "pk": 34, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "University of Texas Southwestern Medical Center ", 
      "address": ""
    }
  }, 
  {
    "pk": 35, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Lightec", 
      "address": "Rua da Quitanda, 90 - 2\u00ba andar\n20011-030 - Rio de Janeiro - RJ\nTel: (21) 3501-9900\nFax: (21) 3501-5302"
    }
  }, 
  {
    "pk": 36, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "US"
      ], 
      "name": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
      "address": ""
    }
  }, 
  {
    "pk": 37, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "NL"
      ], 
      "name": "NedX", 
      "address": ""
    }
  }, 
  {
    "pk": 38, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "wwert", 
      "address": "a13039\nasd\n\n23423"
    }
  }, 
  {
    "pk": 39, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Funda\u00e7\u00e3o Oswaldo Cruz", 
      "address": ""
    }
  }, 
  {
    "pk": 40, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "BR"
      ], 
      "name": "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico", 
      "address": "SEPN 507 Ed. CNPq - Terreo - Sala 7, 0, \n70740-901 - Brasilia - DF\n\n"
    }
  }, 
  {
    "pk": 41, 
    "model": "repository.institution", 
    "fields": {
      "country": [
        "AT"
      ], 
      "name": "United Nations Office On Drugs and Crime (UNODC)", 
      "address": "Vienna International Centre\nWagramer Strasse 5 \nA 1400 Vienna "
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.contact", 
    "fields": {
      "city": "Tabriz", 
      "zip": "51656-65811", 
      "firstname": "Naser", 
      "middlename": "", 
      "lastname": "Safaei", 
      "telephone": "+98-411-3357767", 
      "affiliation": 2, 
      "address": "Daneshgah St, Tabriz Univ Med Sci", 
      "country": [
        "IR"
      ], 
      "email": "drsafaei@yahoo.com"
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.contact", 
    "fields": {
      "city": "Santa Clara", 
      "zip": "Ca. 950504", 
      "firstname": "Candace", 
      "middlename": "", 
      "lastname": "Elek", 
      "telephone": "+1 408-845-3133", 
      "affiliation": 3, 
      "address": "3200 Lakeside Dr.", 
      "country": [
        "US"
      ], 
      "email": "Candace.Elek@av.abbott.com"
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.contact", 
    "fields": {
      "city": "Santa Clara", 
      "zip": "Ca. 950504", 
      "firstname": "Robert", 
      "middlename": "", 
      "lastname": "McGreevy", 
      "telephone": "+1 408-845-3932", 
      "affiliation": 3, 
      "address": "3200 Lakeside Dr.", 
      "country": [
        "US"
      ], 
      "email": "Robert.Mcgreevy@av.abbott.com"
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.contact", 
    "fields": {
      "city": "Oakland", 
      "zip": "345678", 
      "firstname": "John", 
      "middlename": "Henry", 
      "lastname": "Doe", 
      "telephone": "21-23409985", 
      "affiliation": 29, 
      "address": "K Street 456 ", 
      "country": [
        "US"
      ], 
      "email": "jhdoe@aol.com"
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.contact", 
    "fields": {
      "city": "teste", 
      "zip": "123456", 
      "firstname": "teste", 
      "middlename": "teste", 
      "lastname": "teste", 
      "telephone": "11 4448-7897", 
      "affiliation": 3, 
      "address": "teste", 
      "country": [
        "BR"
      ], 
      "email": "teste@teste.com"
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.contact", 
    "fields": {
      "city": "aaa", 
      "zip": "123456", 
      "firstname": "joao", 
      "middlename": "pedro", 
      "lastname": "silva", 
      "telephone": "11 4448-7897", 
      "affiliation": 5, 
      "address": "aaa", 
      "country": [
        "DZ"
      ], 
      "email": "joao@teste.com"
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.contact", 
    "fields": {
      "city": "qqqq", 
      "zip": "12456", 
      "firstname": "Paulo", 
      "middlename": "", 
      "lastname": "Souza", 
      "telephone": "12346", 
      "affiliation": 5, 
      "address": "qqq", 
      "country": [
        "BS"
      ], 
      "email": "paulo@teste.com.br"
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.contact", 
    "fields": {
      "city": "rio de janeiro", 
      "zip": "123456", 
      "firstname": "teste novo contato", 
      "middlename": "xx", 
      "lastname": "yy", 
      "telephone": "1234567", 
      "affiliation": 9, 
      "address": "xxxxx", 
      "country": [
        "BR"
      ], 
      "email": "margot.rj@gmail.com"
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.contact", 
    "fields": {
      "city": "Rio de Janeiro", 
      "zip": "21040-900", 
      "firstname": "Valeria", 
      "middlename": "C", 
      "lastname": "Rolla", 
      "telephone": "+55-21-3865-9607", 
      "affiliation": 6, 
      "address": "", 
      "country": [
        "BR"
      ], 
      "email": "valeria.rolla@ipec.fiocruz.br"
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.contact", 
    "fields": {
      "city": "Rio de Janeiro", 
      "zip": "21040-900", 
      "firstname": "Simone", 
      "middlename": "S", 
      "lastname": "Cavalho", 
      "telephone": "+55 21 38659601", 
      "affiliation": 6, 
      "address": "", 
      "country": [
        "BR"
      ], 
      "email": "simone.carvalho@ipec.fiocruz.br"
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 3, 
      "contact": 1
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 4, 
      "contact": 2
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 22, 
      "contact": 1
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 23, 
      "contact": 1
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 24, 
      "contact": 1
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 28, 
      "contact": 3
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 9, 
      "contact": 5
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.publiccontact", 
    "fields": {
      "status": "Active", 
      "trial": 25, 
      "contact": 8
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 3, 
      "contact": 1
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 4, 
      "contact": 3
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 22, 
      "contact": 2
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 23, 
      "contact": 1
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 24, 
      "contact": 4
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 28, 
      "contact": 1
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 9, 
      "contact": 6
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 31, 
      "contact": 9
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.scientificcontact", 
    "fields": {
      "status": "Active", 
      "trial": 31, 
      "contact": 10
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.sitecontact", 
    "fields": {
      "status": "Active", 
      "trial": 22, 
      "contact": 1
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.sitecontact", 
    "fields": {
      "status": "Active", 
      "trial": 23, 
      "contact": 2
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.sitecontact", 
    "fields": {
      "status": "Active", 
      "trial": 23, 
      "contact": 1
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.sitecontact", 
    "fields": {
      "status": "Active", 
      "trial": 28, 
      "contact": 4
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.sitecontact", 
    "fields": {
      "status": "Active", 
      "trial": 9, 
      "contact": 7
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 36
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "Efeito do tratamento na mudan\u00e7a nominal no volume percentual de ateroma de segmento identificado de art\u00e9ria coron\u00e1ria alvo desde a linha de base ap\u00f3s 18 meses de tratamentomedido pela imagem de ultrassom intravascular de art\u00e9rias coron\u00e1rias", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 36
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 37
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "* Comparar o efeito da pioglitazona e da glimepirida na mudan\u00e7a nominal do volume total do ateroma \r\n* Comparar o efeito da pioglitazona e glimepirida na ocorr\u00eancia de eventos cardiovasculares como um comp\u00f3sito de mortalidade cardiovascular, infarto agudo do mioc\u00e1rdio n\u00e3o=fatal, acidente vascular cerebral n\u00e3o-fatal", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 37
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 38
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "al\u00edvio da dor", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 38
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 39
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "qualidade de vida", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 39
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 40
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "1", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 40
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 41
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "2", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 41
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 42
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "A primeira ocorr\u00eancia de qual um dos seguintes desfechos clinicamente significativos: \r\nmorte\r\nparada card\u00edaca que requer desfribila\u00e7\u00e3o ou cardiovers\u00e3o\r\ntaquicardia ventricular embasada por dicumenta\u00e7\u00e3o que requer cardiovers\u00e3o\r\nnovo desenvolvimento de insufici\u00eancia card\u00edaca congestiva sintom\u00e1tica\r\nimplanta\u00e7\u00e3o de marcapasso ou desfibrilador\r\nacidente vascular encef\u00e1lico ou qualquer outro evento tromb\u00f3tico em pacientes com fen\u00f4menos tromboemb\u00f3licos pr\u00e9vios", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 42
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 43
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "Desenvolvimento de qualquer uma das seguintes mudan\u00e7as ecocardiogr\u00e1ficas: \r\naneurisma ventricular\r\nredu\u00e7\u00e3o da fra\u00e7\u00e3o de eje\u00e7\u00e3o ventricular esquerda > 5%, aumento na disfun\u00e7\u00e3o diast\u00f3lica ventricular esquerda > 5.0 mm  comparada \u00e0 avalia\u00e7\u00e3o inicial\r\nprogress\u00e3o na classe funcional da New York Heart Association (NYHA) em pelo menos uma categoria, avalia\u00e7\u00e3o da seguran\u00e7a (eventos adversos: dermatite, neuropatia perif\u00e9rica, intoler\u00e2ncia gastrointestinal, leucopenia [2500 x 10^9 L]), toler\u00e2ncia e ader\u00eancia ao tratamento", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 43
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 44
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "Estudo prospectivo cego para o investigador que envolve 25 homens e mulheres adultos com vitiligo no dorso das m\u00e3os. Ministransplante punch ser\u00e1 realizado em ambas as m\u00e3os retirando a pele de coxas e/ou n\u00e1degas. Tratamentos com luz ser\u00e3o administrados uma semana ap\u00f3s o transplante. Uma m\u00e3o receber\u00e1 luz ultravioleta B de banda estreita e a outra receber\u00e1 tratamento com luz focal de 308-nm. Os tratamentos de luz ser\u00e3o administrados 3 vezes por semana durante 12 semanas. Uma visita de seguimento de longo prazo ser\u00e1 completada na 25a semana. O investigador ir\u00e1 avaliar os participantes nas semanas 4, 7, 13 e 25, al\u00e9m de rastreamento e avalia\u00e7\u00f5es/procedimentos no in\u00edcio do estudo.", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 44
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 45
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "Pwercentual da repigmenta\u00e7\u00e3o dos transplantes individuais sobreviventes, percntual de repigmenta\u00e7\u00e3o de todos os transplantes sobreviventes e percentual de repigmenta\u00e7\u00e3o das les\u00f5es de pele com cada fonte de luz. Tempo total do estudo: 25 semanas. ", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 45
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 46
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "incid\u00eancia de pr\u00e9-eclampsia", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 46
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 47
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "propor\u00e7\u00e3o de pacientes com carga viral inferior a 80 ao final do tratamento da tuberculose \r\n\r\n[Per\u00edodo de observa\u00e7\u00e3o: 6 meses] ", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 47
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 48
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "propor\u00e7\u00e3o de eventos adversos em cada grupo \r\n\r\n[Per\u00edodo de observa\u00e7\u00e3o: 6 meses]", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 48
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 49
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "reconstitui\u00e7\u00e3o imunol\u00f3gica \r\n\r\n[Per\u00edodo de observa\u00e7\u00e3o: 6 meses]", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 49
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "es", 
      "object_id": 50
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.outcometranslation", 
    "fields": {
      "description": "Genotipagem da resist\u00eancia \r\n\r\n[Per\u00edodo de observa\u00e7\u00e3o: 6 meses]", 
      "content_type": [
        "repository", 
        "outcome"
      ], 
      "language": "pt-br", 
      "object_id": 50
    }
  }, 
  {
    "pk": 1, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "en", 
      "object_id": 15
    }
  }, 
  {
    "pk": 2, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "cefal\u00e9ia", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 15
    }
  }, 
  {
    "pk": 3, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 15
    }
  }, 
  {
    "pk": 4, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "en", 
      "object_id": 16
    }
  }, 
  {
    "pk": 5, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as dos animais", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 16
    }
  }, 
  {
    "pk": 6, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades de los animales", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 16
    }
  }, 
  {
    "pk": 7, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "en", 
      "object_id": 17
    }
  }, 
  {
    "pk": 8, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 17
    }
  }, 
  {
    "pk": 9, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 17
    }
  }, 
  {
    "pk": 10, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 18
    }
  }, 
  {
    "pk": 11, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "melanoma ", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 18
    }
  }, 
  {
    "pk": 12, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 19
    }
  }, 
  {
    "pk": 13, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "melanoma irressec\u00e1vel ou metast\u00e1tico", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 19
    }
  }, 
  {
    "pk": 14, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Neoplasias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 20
    }
  }, 
  {
    "pk": 15, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Neoplasias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 20
    }
  }, 
  {
    "pk": 16, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 21
    }
  }, 
  {
    "pk": 17, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "melanoma", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 21
    }
  }, 
  {
    "pk": 18, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades nutricionales y metab\u00f3licas", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 22
    }
  }, 
  {
    "pk": 19, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as nutricionais e metab\u00f3licas", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 22
    }
  }, 
  {
    "pk": 20, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 23
    }
  }, 
  {
    "pk": 21, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Diabetes mellitus n\u00e3o-insulino dependente", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 23
    }
  }, 
  {
    "pk": 22, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 24
    }
  }, 
  {
    "pk": 23, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "asfdasdfafda", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 24
    }
  }, 
  {
    "pk": 24, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 25
    }
  }, 
  {
    "pk": 25, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "1111111111", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 25
    }
  }, 
  {
    "pk": 26, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 26
    }
  }, 
  {
    "pk": 27, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "glicemia", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 26
    }
  }, 
  {
    "pk": 28, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 27
    }
  }, 
  {
    "pk": 29, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "bevacizumabe", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 27
    }
  }, 
  {
    "pk": 30, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 28
    }
  }, 
  {
    "pk": 31, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "placebo", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 28
    }
  }, 
  {
    "pk": 32, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 29
    }
  }, 
  {
    "pk": 33, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 29
    }
  }, 
  {
    "pk": 34, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 30
    }
  }, 
  {
    "pk": 35, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7a de Chagas (cr\u00f4nica) com comprometimento card\u00edaco", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 30
    }
  }, 
  {
    "pk": 36, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades parasitarias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 31
    }
  }, 
  {
    "pk": 37, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as parasit\u00e1rias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 31
    }
  }, 
  {
    "pk": 38, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades parasitarias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 32
    }
  }, 
  {
    "pk": 39, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as parasit\u00e1rias", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 32
    }
  }, 
  {
    "pk": 40, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades de la piel y tejido conjuntivo", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 33
    }
  }, 
  {
    "pk": 41, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as da pele e do tecido conjuntivo", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 33
    }
  }, 
  {
    "pk": 42, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 34
    }
  }, 
  {
    "pk": 43, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "vitiligo", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 34
    }
  }, 
  {
    "pk": 44, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 35
    }
  }, 
  {
    "pk": 45, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "pigmenta\u00e7\u00e3o da pele", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 35
    }
  }, 
  {
    "pk": 46, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 11
    }
  }, 
  {
    "pk": 47, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 11
    }
  }, 
  {
    "pk": 48, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Isquemia Mioc\u00e1rdica", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 12
    }
  }, 
  {
    "pk": 49, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Isquemia Mioc\u00e1rdica", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 12
    }
  }, 
  {
    "pk": 50, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Estenosis Coronaria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 13
    }
  }, 
  {
    "pk": 51, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Estenose Coron\u00e1ria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 13
    }
  }, 
  {
    "pk": 52, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Reestenosis Coronaria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 14
    }
  }, 
  {
    "pk": 53, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Reestenose Coron\u00e1ria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 14
    }
  }, 
  {
    "pk": 54, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 1
    }
  }, 
  {
    "pk": 55, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as cardiovasculares", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 1
    }
  }, 
  {
    "pk": 56, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Isquemia Mioc\u00e1rdica", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 2
    }
  }, 
  {
    "pk": 57, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Isquemia Mioc\u00e1rdica", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 2
    }
  }, 
  {
    "pk": 58, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedad de la Arteria Coronaria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 3
    }
  }, 
  {
    "pk": 59, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7a da Art\u00e9ria Coronariana", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 3
    }
  }, 
  {
    "pk": 60, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Estenosis Coronaria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 7
    }
  }, 
  {
    "pk": 61, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Estenose Coron\u00e1ria", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 7
    }
  }, 
  {
    "pk": 62, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "F\u00edstula Arteriovenosa", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 9
    }
  }, 
  {
    "pk": 63, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "F\u00edstula Arteriovenosa", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 9
    }
  }, 
  {
    "pk": 64, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 36
    }
  }, 
  {
    "pk": 65, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "XE321", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 36
    }
  }, 
  {
    "pk": 66, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Infecciones bacterianas y micosis", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 37
    }
  }, 
  {
    "pk": 67, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Infec\u00e7\u00f5es bacterianas e micoses", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 37
    }
  }, 
  {
    "pk": 68, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Enfermedades del sistema inmune", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 38
    }
  }, 
  {
    "pk": 69, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Doen\u00e7as do sistema imune", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 38
    }
  }, 
  {
    "pk": 70, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 39
    }
  }, 
  {
    "pk": 71, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Tuberculose n\u00e3o especificada das vias respirat\u00f3rias, com confirma\u00e7\u00e3o bacteriol\u00f3gica e histol\u00f3gica", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 39
    }
  }, 
  {
    "pk": 72, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 40
    }
  }, 
  {
    "pk": 73, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Rifampina", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 40
    }
  }, 
  {
    "pk": 74, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Transfusi\u00f3n de Sangre Aut\u00f3loga", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "es", 
      "object_id": 41
    }
  }, 
  {
    "pk": 75, 
    "model": "repository.descriptortranslation", 
    "fields": {
      "text": "Transfus\u00e3o de Sangue Aut\u00f3loga", 
      "content_type": [
        "repository", 
        "descriptor"
      ], 
      "language": "pt-br", 
      "object_id": 41
    }
  }
]
